Get the Stockscreener App
28.69
2.46%
0.69
Quidelortho Corporation stock is traded at $28.69, with a volume of 1.20M.
It is up +2.46% in the last 24 hours and up +12.78% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
See More
Previous Close:
$28.00
Open:
$28.08
24h Volume:
1.20M
Relative Volume:
0.84
Market Cap:
$1.95B
Revenue:
$2.74B
Net Income/Loss:
$-441.40M
P/E Ratio:
-4.3869
EPS:
-6.54
Net Cash Flow:
$13.00M
1W Performance:
+2.83%
1M Performance:
+12.78%
6M Performance:
-27.88%
1Y Performance:
-34.17%
1-Day Range:
$27.91
$29.25
1-Week Range:
$26.80
$29.25
52-Week Range:
$22.05
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
28.69 | 1.90B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
132.66 | 228.64B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.50 | 156.70B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.41 | 148.97B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 117.96B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.34 | 47.69B | 5.69B | 1.41B | 577.90M | 6.95 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
Is QuidelOrtho Corporation stock entering bullish territoryJuly 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
Real time breakdown of QuidelOrtho Corporation stock performanceJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Can QuidelOrtho Corporation hit a new high this monthJuly 2025 Outlook & Daily Entry Point Alerts - Newser
Top chart patterns to watch in QuidelOrtho CorporationFed Meeting & Comprehensive Market Scan Reports - Newser
Real time pattern detection on QuidelOrtho Corporation stockQuarterly Earnings Summary & Verified Stock Trade Ideas - Newser
Published on: 2025-08-29 18:10:34 - Newser
Market reaction to QuidelOrtho Corporation’s recent newsEarnings Growth Summary & Fast Exit/Entry Strategy Plans - Newser
Comparing QuidelOrtho Corporation in custom built stock radarsWatch List & Daily Stock Trend Watchlist - Newser
Using AI based signals to follow QuidelOrtho CorporationTake Profit & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-08-29 14:22:41 - Newser
Visual trend scoring systems applied to QuidelOrtho CorporationJuly 2025 Movers & Reliable Entry Point Alerts - Newser
Multi asset correlation models including QuidelOrtho CorporationJuly 2025 Snapshot & Community Verified Trade Alerts - Newser
Using flow based indicators on QuidelOrtho CorporationMarket Rally & Smart Money Movement Tracker - Newser
Trend analysis for QuidelOrtho Corporation this weekCPI Data & Advanced Technical Analysis Signals - Newser
Is QuidelOrtho Corporation a candidate for recovery playTrade Volume Summary & Detailed Earnings Play Strategies - Newser
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference - Eastern Progress
How high can QuidelOrtho Corporation stock goJuly 2025 Analyst Calls & AI Enhanced Trading Signals - Newser
QuidelOrtho's Strategic Visibility in the Global Diagnostics Landscape - AInvest
Is QuidelOrtho Corporation a top pick in the sectorWeekly Risk Report & Weekly Stock Breakout Alerts - sundaytimes.kr
QuidelOrtho to Participate in Baird 2025 Global Healthcare Conference: A Strategic Move for the In Vitro Diagnostic Leader - AInvest
How moving averages guide QuidelOrtho Corporation tradingGDP Growth & Daily Entry Point Trade Alerts - Newser
Published on: 2025-08-28 10:19:30 - Newser
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference | QDEL Stock News - GuruFocus
QuidelOrtho to participate in Baird 2025 Global Healthcare Conference. - AInvest
Global Diagnostics Leader QuidelOrtho Set for Strategic Discussion at Baird Healthcare Conference 2025 - Stock Titan
What institutional flow reveals about QuidelOrtho CorporationJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
Lateral Flow Assays Market to Grow at a CAGR of 7.5% During the Forecast Period (2025 – 2030): Wissen Research - GlobeNewswire Inc.
How QuidelOrtho Corporation stock performs during market volatility2025 Market Overview & Fast Exit/Entry Strategy Plans - Newser
Measuring QuidelOrtho Corporation’s beta against major indices2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Reversal indicators forming on QuidelOrtho Corporation stockJuly 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Quantitative breakdown of QuidelOrtho Corporation recent moveWeekly Gains Summary & Technical Analysis for Trade Confirmation - Newser
Using data models to predict QuidelOrtho Corporation stock movement2025 Market Overview & Community Consensus Stock Picks - Newser
When is the best time to buy QuidelOrtho Corporation stockWeekly Risk Summary & Smart Allocation Stock Reports - Newser
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):